Lower Baseline LDL Cholesterol Affects All-cause Mortality in Patients with First Percutaneous Coronary Intervention

• Published in: Biomedical and environmental sciences 2023-04, Vol.36 (4), p.324-333
• Main Authors: CHEN, Xi, CHEN, Hao, LU, Wei Bo, ZHANG, Min, TAO, Yuan, WANG, Qing Cheng, FU, Guo Sheng, ZHANG, Wen Bin
• Format: Article
• Language: English
• Subjects: Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Clinical outcomes; Coronary artery disease; Coronary Artery Disease - surgery; Humans; Low-density lipoprotein cholesterol; Percutaneous Coronary Intervention - adverse effects; Retrospective Studies; Risk Factors; Stroke - etiology; Treatment Outcome
• ISSN: 0895-3988; 2214-0190
• DOI: 10.3967/bes2023.038

Foreign studies have reported that coronary artery disease (CAD) patients with high baseline low-density lipoprotein cholesterol (LDL-C) may have a good prognosis, which is called the “cholesterol paradox”. This study aimed to examine whether the “cholesterol paradox” also exists in the Chinese population. A total of 2,056 patients who underwent the first percutaneous coronary intervention (PCI) between 2014 and 2016 were enrolled in this retrospective cohort study and classified into two groups based on baseline LDL-C = 2.6 mmol/L (100 mg/dL). The outcomes of interest included major adverse cardiovascular events (MACE), all-cause mortality, recurrent nonfatal myocardial infarction, unexpected coronary revascularization, or any nonfatal stroke. All-cause mortality occurred in 8 patients (0.7%) from the low-LDL-C group and 12 patients (2.4%) in the high-LDL-C group, with a significant difference between the two groups (adjusted hazard ratio: 4.030, 95% confidence interval: 1.088–14.934; P = 0.037). However, no significant differences existed for the risk of MACE or other secondary endpoints, such as unexpected revascularization, nor any nonfatal stroke in the two groups. In this study, a high baseline LDL-C was not associated with a low risk of clinical outcomes in CAD patients undergoing first PCI, which suggested that the “cholesterol paradox” may be inapplicable to Chinese populations.